PATENT CLAIM ANALYSIS

Application Number: 15762895
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["546", "084000"]

Abstract:
Provided are crystal forms I, II, III and IV of a pyrroloquinoline quinone sodium salt and a preparation method thereof. Also provided are a pharmaceutical composition, a cosmetic composition, a functional food or a nutritional agent containing the above-mentioned crystal forms. The crystal forms have excellent properties in terms of solubility, crystal stability, hygroscopicity and the like.

Claim (Index 6):
The crystal form II of pyrroloquinoline quinone disodium salt according to  claim 5 , wherein Cu target is used, the X-ray powder diffraction pattern of the crystal form II also has characteristic peaks at the following 2\u03b8 diffraction angles: 8.9\u00b10.2\u00b0, 15.6\u00b10.2\u00b0, 18.0\u00b10.2\u00b0, 23.5\u00b10.2\u00b0 and 28.2\u00b10.2\u00b0.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 90.0
- Lexical Diversity: 1.53488
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14441571', '14897926', '15123378', '15760090', '13383472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7958541929052598
- 35 USC 102 Novelty (BERT): 0.5545219749267061
- Combined Prediction Score: 0.7717209711074045
- Mean Citation Score: 370.529484
- Max Citation Score: 418.04538
- Similarity Product: 332.38699852383263

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test